Salix acquires gastrointestinal drugs rights
Under the terms of the agreement, Salix will also make up to $6 million in potential sales-based milestone payments to Merck. Pepcid is a prescription product indicated for
The US Food and Drug Administration (FDA) has granted accelerated approval to Bristol Myers Squibb’s (BMS) Zenbexus (iberdomide), along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma (MM) patients.